Boundless Bio Quote - BOLD

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.90

Bid

1.88

Ask

1.99

Volume

1.90 Day's Range 1.90

1.80 52 Week Range 59.97

Market Cap

42.37M

Previous Close

1.90

Open

1.90

Last Trade

1.895

Last Trade Time

08:54:53

Financial Volume

VWAP

Average Volume (3m)

91,181

Shares Outstanding

22,300,043

Dividend Yield

PE Ratio

-0.86

Earnings Per Share (EPS)

-2.22

Revenue

Net Profit

-49.43M

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical t... Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.boundlessbio.com

Headquarters

Wilmington, Delaware, USA

Founded

Boundless Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BOLD. The last closing price for Boundless Bio was US$1.90. Over the last year, Boundless Bio shares have traded in a share price range of US$ 1.80 to US$ 59.97.

Boundless Bio currently has 22,300,043 shares outstanding. The market capitalization of Boundless Bio is US$42.37 million. Boundless Bio has a price to earnings ratio (PE ratio) of -0.86.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.11	-5.47263681592	2.01	2.1	1.8	117606	1.92900034	CS
4	-0.56	-22.7642276423	2.46	2.54	1.8	59357	2.05595175	CS
12	-0.65	-25.4901960784	2.55	3.54	1.8	91181	2.48058507	CS
26	-1.92	-50.2617801047	3.82	4.72	1.8	80831	2.78146044	CS
52	-58.07	-96.8317492079	59.97	59.97	1.8	91269	6.08167004	CS
156	-58.07	-96.8317492079	59.97	59.97	1.8	30262	6.08167004	CS
260	-58.07	-96.8317492079	59.97	59.97	1.8	20668	6.08167004	CS

BOLD - Frequently Asked Questions (FAQ)

What is the current Boundless Bio share price?

The current share price of Boundless Bio is US$ 1.90

How many Boundless Bio shares are in issue?

Boundless Bio has 22,300,043 shares in issue

What is the market cap of Boundless Bio?

The market capitalisation of Boundless Bio is USD 42.37M

What is the 1 year trading range for Boundless Bio share price?

Boundless Bio has traded in the range of US$ 1.80 to US$ 59.97 during the past year

What is the PE ratio of Boundless Bio?

The price to earnings ratio of Boundless Bio is -0.86

What is the reporting currency for Boundless Bio?

Boundless Bio reports financial results in USD

What is the latest annual profit for Boundless Bio?

The latest annual profit of Boundless Bio is USD -49.43M

What is the registered address of Boundless Bio?

The registered address for Boundless Bio is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Boundless Bio website address?

The website address for Boundless Bio is www.boundlessbio.com

Which industry sector does Boundless Bio operate in?

Boundless Bio operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
STAKSTAK Inc	US$ 3.30 (112.90%)	28.34k
ORGOOrganogenesis Holdings Inc	US$ 5.06 (64.82%)	18.15M
NVVENuvve Holding Corporation	US$ 3.74 (55.83%)	43.17M
ARBBARB IOT Group Ltd	US$ 0.704 (46.67%)	28.31M
PMAXPowell Max Ltd	US$ 0.4764 (33.82%)	69.11M
NVNINVNI Group Ltd	US$ 0.713248 (-64.34%)	16.21M
DHDefinitive Healthcare Corporation	US$ 2.60 (-47.15%)	518.23k
SPGCSacks Parente Golf Inc	US$ 0.2322 (-42.81%)	19.21M
PRAXPraxis Precision Medicines Inc	US$ 38.53 (-40.75%)	854.6k
MBIOMustang Bio Inc	US$ 1.89 (-31.02%)	152.72k
PMAXPowell Max Ltd	US$ 0.4778 (34.21%)	68.28M
NVDANVIDIA Corporation	US$ 118.51 (-1.36%)	67.18M
TRNRInteractive Strength Inc	US$ 1.8751 (22.56%)	58.07M
VRPXVirpax Pharmaceuticals Inc	US$ 0.2578 (13.47%)	55.19M
ADTXAditxt Inc	US$ 0.071 (2.45%)	44.66M